Nomura Holdings
OLMA icon

Nomura Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

Nomura Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$574K Hold
38,500
– – ﹤0.01% 1320
2025
Q4 		$963K Buy
+38,500
New +$685K ﹤0.01% 1350

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Nomura Holdings's OLMA Position: Q1 2026 in Review

Nomura Holdings opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 41,960 shares worth $626K. The stake represents ﹤0.01% of the portfolio and ranks #1301 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in OLMA as recently as Q4 2021.

Nomura Holdings first reported a position in OLMA in Q4 2021 and has held it in 2 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Nomura Holdings held 41,960 shares of Olema Pharmaceuticals worth $626K as of Q1 2026.
  • Olema Pharmaceuticals was a new Nomura Holdings position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1301 holding.
  • Nomura Holdings first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 2 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.